Setting up the EATRIS infrastructure which is targeted to a wide range of diseases and a broad spectrum of treatments needs the concerted action of countries. By the joint activity of its partners, EATRIS will create a highly productive research environment throughout Europe by using European synergies to set up state-of-the-art facilities combined with translational expertise and open them to the research community. This concerted action will be an important contribution to reinforce the momentum for innovation and bring back investments in the LifeScience sector to Europe.

Currently ten European countries are partners in the EATRIS consortium: Denmark, Finland, France, Germany, Italy, Norway, The Netherlands, Spain, Sweden and the UK.

Each country is represented politically and scientifically. The "Governmental Partner" represents the national research funding body while the "Scientific Partner" represents the national translational biomedical research community.